Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Gross Margin (2016 - 2025)

Phibro Animal Health has reported Gross Margin over the past 14 years, most recently at 35.48% for Q4 2025.

  • Quarterly results put Gross Margin at 35.48% for Q4 2025, up 254.0% from a year ago — trailing twelve months through Dec 2025 was 31.89% (up 6.0% YoY), and the annual figure for FY2025 was 30.85%, up 9.0%.
  • Gross Margin for Q4 2025 was 35.48% at Phibro Animal Health, up from 32.92% in the prior quarter.
  • Over the last five years, Gross Margin for PAHC hit a ceiling of 35.48% in Q4 2025 and a floor of 29.05% in Q2 2025.
  • Median Gross Margin over the past 5 years was 30.74% (2022), compared with a mean of 31.14%.
  • Biggest five-year swings in Gross Margin: skyrocketed 279bps in 2024 and later tumbled -285bps in 2025.
  • Phibro Animal Health's Gross Margin stood at 30.37% in 2021, then rose by 4bps to 31.63% in 2022, then dropped by -1bps to 31.45% in 2023, then grew by 5bps to 32.94% in 2024, then rose by 8bps to 35.48% in 2025.
  • The last three reported values for Gross Margin were 35.48% (Q4 2025), 32.92% (Q3 2025), and 29.05% (Q2 2025) per Business Quant data.